Michigan basketball signee Marcus Moller diagnosed with testicular cancer

Michigan Wolverines basketball signee Marcus Moller has been diagnosed with testicular cancer and will be pausing his basketball career temporarily, according to a release on Friday.

The 7-3 Danish product signed with the program for its 2026-27 and is receiving treatment in his home country. He was playing in Spain for Unicaja Baloncesto de Málaga.

“In recent days, [Marcus Moller] has had to face a medical situation that requires him to temporarily suspend his athletic activities,” the club said. “Following medical tests, he has been diagnosed with testicular cancer.”

“Currently, Marcus is in Denmark, where he is receiving medical treatment, assisted by specialized professionals and surrounded by the support of his family and closest friends. At this time, the absolute priority is his health and well-being, so both the player and the club have agreed to focus all efforts on his recovery for as long as necessary.

“From Unicaja Baloncesto, we want to send Marcus all our love, support, and strength during this process. We are convinced that he will face this challenge with the courage and determination that have always characterized him.

“We appreciate your respect and understanding during this delicate situation that our player is going through. We are with you, Marcus.”

Michigan made a statement on Friday afternoon, standing by Moller and revealing it still hopes to have him in Ann Arbor when it is time to enroll this summer.

“We want Marcus to know that he will not face this alone, as so many people are thinking of him and sending him strength every single day,” U-M basketball said. “While he focuses on his health and recovery, we truly look forward to having Marcus with us in Ann Arbor this summer and are beyond excited for his future as a Wolverine.”

Moller, who committed to Michigan in July, is one of four signees in the 2026 class along with forward Quinn Costello, guard Joseph Hartman and forward Malachi Brown.